Considerations for managing chronic obstructive pulmonary disease in the elderly

por Taffet, George E, Donohue, James F, Altman, Pablo R
Publicado 2013

Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety

por Price, David, Castro, Mario, Bourdin, Arnaud, Fucile, Sebastian, Altman, Pablo
Publicado 2020

Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials

por D’Urzo, Anthony, Bader, Giovanni, Shen, Steven, Goyal, Pankaj, Altman, Pablo
Publicado 2018

The prostaglandin D(2) receptor 2 pathway in asthma: a key player in airway inflammation

por Domingo, Christian, Palomares, Oscar, Sandham, David A., Erpenbeck, Veit J., Altman, Pablo
Publicado 2018

Addressing unmet needs in the treatment of COPD

por Patalano, Francesco, Banerji, Donald, D’Andrea, Peter, Fogel, Robert, Altman, Pablo, Colthorpe, Paul
Publicado 2014

Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist

por van der Molen, Thys, van Boven, Job F. M., Maguire, Terence, Goyal, Pankaj, Altman, Pablo
Publicado 2016

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over tr...

por Altman, Pablo, Wehbe, Luis, Dederichs, Juergen, Guerin, Tadhg, Ament, Brian, Moronta, Miguel Cardenas, Pino, Andrea Valeria, Goyal, Pankaj
Publicado 2018

The rationale for development of ligelizumab in food allergy

por Wood, Robert A., Chinthrajah, R. Sharon, Eggel, Alexander, Bottoli, Ivan, Gautier, Aurelie, Woisetschlaeger, Maximilian, Tassinari, Paolo, Altman, Pablo
Publicado 2022

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

por Rodrigo, Gustavo J, Price, David, Anzueto, Antonio, Singh, Dave, Altman, Pablo, Bader, Giovanni, Patalano, Francesco, Fogel, Robert, Kostikas, Konstantinos
Publicado 2017

Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond

por Mall, Marcus A., Criner, Gerard J., Miravitlles, Marc, Rowe, Steven M., Vogelmeier, Claus F., Rowlands, David J., Schoenberger, Matthias, Altman, Pablo
Publicado 2023

Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis

por Donohue, James F, Betts, Keith A, Du, Ella Xiaoyan, Altman, Pablo, Goyal, Pankaj, Keininger, Dorothy L, Gruenberger, Jean-Bernard, Signorovitch, James E
Publicado 2017

Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis

por Ntritsos, Georgios, Franek, Jacob, Belbasis, Lazaros, Christou, Maria A, Markozannes, Georgios, Altman, Pablo, Fogel, Robert, Sayre, Tobias, Ntzani, Evangelia E, Evangelou, Evangelos
Publicado 2018

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data

por D’Urzo, Anthony D, Kerwin, Edward M, Chapman, Kenneth R, Decramer, Marc, DiGiovanni, Robert, D’Andrea, Peter, Hu, Huilin, Goyal, Pankaj, Altman, Pablo
Publicado 2015